<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33125541</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous&#xa0;variant and a review of the literature.</ArticleTitle><Pagination><StartPage>1351</StartPage><EndPage>1357</EndPage><MedlinePgn>1351-1357</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10283-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Accumulating evidence shows that SQSTM1 plays a vital role in the pathogenesis of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which represent a neurodegenerative disease continuum. Here, we report a novel SQSTM1 variant in a patient presenting with progressive nonfluent aphasia (PNFA) and progressive bulbar palsy (PBP). Relevant literature about FTD and FTD-ALS caused by SQSTM1 mutation was reviewed to better understand its clinical features.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We collected data from a 66-year-old male patient with a novel heterozygous variant (c.995C&#x2009;&gt;&#x2009;G, p.S332X) in the SQSTM1 gene who was diagnosed with PNFA and PBP and performed a PubMed literature search using the advanced research criteria: [("frontotemporal lobar degeneration") OR ("frontotemporal dementia") OR ("amyotrophic lateral sclerosis") OR ("motor neuron disease")] AND ("SQSTM1"). The clinical features of FTD and FTD-ALS related to SQSTM1 mutation were summarized based on previous cases and our new case.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The initial symptom of the current patient was progressive verb finding difficulties and effortful speech output, which developed into dysarthria and dysphagia in subsequent months. The results, including tongue atrophy, fasciculations, neurogenic changes, and mild left dominant hypometabolism of 18F-fluorodeoxyglucose PET in the frontal cortex, suggest the possibility of PNFA and PBP. A novel likely pathogenic heterozygous variant (c.995C&#x2009;&gt;&#x2009;G, p.S332X) in the SQSTM1 gene was identified. The literature search revealed a total of 33 FTD and FTD-ALS cases related to the SQSTM1 mutation with detailed clinical information. The mean age of onset (including our patient) was 63.5&#x2009;&#xb1;&#x2009;9.7&#xa0;years. bvFTD was the most common clinical phenotype. The missense mutation in the SQSTM1 gene coding region and the UBA domain involvement are its main genetic characteristics.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although rare, mutations in SQSTM1 can lead to various clinical subtypes of FTD and FTD-ALS, including the rare combination of PNFA and PBP. Exon missense mutation is the main type of mutation, which is common in the UBA domain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Weishuai</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang, 110004, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang, 110004, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang, 110004, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Dongming</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang, 110004, Liaoning, China. zdm_sj@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018225091</GrantID><Agency>Natural Science Foundation of Liaoning Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Progressive bulbar palsy</Keyword><Keyword MajorTopicYN="N">Progressive nonfluent aphasia</Keyword><Keyword MajorTopicYN="N">SQSTM1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33125541</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10283-x</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10283-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hogan DB, Jett&#xe9; N, Fiest KM, Roberts JI, Pearson D, Smith EE, Roach P, Kirk A, Pringsheim T, Maxwell CJ (2016) The prevalence and incidence of frontotemporal dementia: a systematic review. Can J Neurol Sci 43:S96&#x2013;S109</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.25</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman DS et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;2477</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Kiernan MC, Vucic S, Hodges JR (2011) Motor neuron dysfunction in frontotemporal dementia. Brain 134:2582&#x2013;2594</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney E, Vucic S, Hodges JR, Kiernan MC (2015) Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother 15:509&#x2013;522</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2015.1034108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieben A, Van Langenhove T, Engelborghs S, Martin J, Boon P, Cras P, De Deyn PP, Santens P, Van Broeckhoven C, Cruts M (2012) The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 124:353&#x2013;372</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1029-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea SL, Walsh J, Layfield R, Ratajczak T, Xu J (2013) New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of paget&#x2019;s disease of bone. Endocr Rev 34:501&#x2013;524</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2012-1034</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582&#x2013;1588</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/340731</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, Camuzat A, Guerreiro R, Bouya-Ahmed K, Bras J, Nicolas G, Gabelle A, Didic M, De Septenville A, Millecamps S, Lenglet T, Latouche M, Kabashi E, Campion D, Hannequin D, Hardy J, Brice A (2013) SQSTM1 mutations in french patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol 70:1403&#x2013;1410</Citation><ArticleIdList><ArticleId IdType="pubmed">24042580</ArticleId><ArticleId IdType="pmc">4199096</ArticleId></ArticleIdList></Reference><Reference><Citation>Der Zee JV, Van Langenhove T, Kovacs GG et al (2014) Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol 128:397&#x2013;410</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1298-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino E, Rainero I, Chio A, Rogaeva E, Galimberti D, Fenoglio P, Grinberg Y, Isaia G, Calvo A, Gentile S, Bruni AC, St George-Hyslop PH, Scarpini E, Gallone S, Pinessi L (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79:1556&#x2013;1562</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826e25df</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology. Genet Med 17:405&#x2013;424</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Rong Z, Li W, Zheng H, Xiao S, Li X (2018) Identification of a novel hemizygous SQSTM1 nonsense mutation in atypical behavioral variant frontotemporal dementia. Front Aging Neurosci 10:26&#x2013;26</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00026</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutoleaubretonniere C, Camuzat A, Ber IL, Bouya-Ahmed K, Guerreiro R, Deruet AL, Evrard C, Bras J, Lamy E, Auffray-Calvier E, Pallardy A, Hardy J, Brice A, Derkinderen P, Vercelletto M (2018) A phenotype of atypical apraxia of speech in a family carrying SQSTM1 mutation. J Alzheimers Dis 43:625&#x2013;630</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141512</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller L, Rollinson S, Callister JB, Young K, Harris J, Gerhard A, Neary D, Richardson A, Snowden J, Mann DM, Pickering-Brown SM (2015) p62/SQSTM1 analysis in frontotemporal lobar degeneration. Neurobiol Aging 36:1603.e5-1603.e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.08.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwendraat C, Wilke C, Sim&#xf3;n-S&#xe1;nchez J, Jansen IE, Reifschneider A, Capell A, Haass C, Castillo-Lizardo M, Biskup S, Maetzler W, Rizzu P, Heutink P, Synofzik M (2018) The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects. Genet Med 20:240&#x2013;249</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2017.102</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida MR, Letra L, Pires P, Santos A, Rebelo O, Guerreiro R, van der Zee J, Van Broeckhoven C, Santana I (2016) Characterization of an FTLD-PDB family with the coexistence of SQSTM1 mutation and hexanucleotide (G4C2) repeat expansion in C9orf72 gene. Neurobiol Aging 40:1&#x2013;1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.12.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S (2011) Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 70:349&#x2013;359</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea SL, Majcher V, Searle MS, Layfield R (2014) SQSTM1 mutations&#x2013;bridging Paget disease of bone and ALS/FTLD. Exp Cell Res 325:27&#x2013;37</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2014.01.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, Zheng JG, Shi Y, Siddique N, Arrat H, Donkervoort S, Ajroud-Driss S, Sufit RL, Heller SL, Deng HX, Siddique T (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68:1440&#x2013;1446</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gass J, Cannon A, Mackenzie IR et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988&#x2013;3001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddl241</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy NA, Arthur KC, Tienari PJ, Houlden H, Chi&#xf2; A, Traynor BJ (2017) Age-related penetrance of the C9orf72 repeat expansion. Sci Rep 7:2116</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02364-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323&#x2013;330</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, Maat-Kievit JA, Anar B, Kaat LD, Breedveld GJ, Dooijes D, Rozemuller JM, Bronner IF, Rizzu P, van Swieten JC (2008) Distinct genetic forms of frontotemporal dementia. Neurology 71:1220&#x2013;1226</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000319702.37497.72</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Fifita JA, Vucic S, Durnall JC, Kiernan MC, Blair IP, Nicholson GA (2013) Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry 84:931&#x2013;935</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood EM, Falcone D, Suh E, Irwin DJ, Chen-Plotkin AS, Lee EB, Xie SX, Van Deerlin VM, Grossman M (2013) Development andvalidation of pedigree classification criteria for frontotemporallobar degeneration. JAMA Neurol 70:1411&#x2013;1417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3956</ArticleId></ArticleIdList></Reference><Reference><Citation>Portet F, Cadilhac C, Touchon J, Camu W (2001) Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord 2:23&#x2013;29</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608201300079382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Li S, Zhao Y, Ma X, Zhang K, He X, Wang Z (2013) Interaction domains of p62: a bridge between p62 and selective autophagy. DNA Cell Biol 32:220&#x2013;227</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2012.1915</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24:8055&#x2013;8068</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.18.8055-8068.2004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavey JR, Ralston SH, Sheppard PW, Ciani B, Gallagher TR, Long JE, Searle MS, Layfield R (2006) Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget&#x2019;s disease of bone. Calcif Tissue Int 78:271&#x2013;277</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-005-1299-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Str&#xf6;m AL, Kwinter DM, Kilty R, Zhang J, Shi P, Fu W, Wooten MW, Zhu H (2009) Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem 111:1062&#x2013;1073</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06388.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>